Susanna High

Susanna High

Director Ejecutivo en
Paragon Therapeutics, Inc.
.
58 años
Health Technology
Consumer Services
Commercial Services

Perfil

Susanna G.
High
is currently the Chief Executive Officer at Paragon Therapeutics, Inc. She previously held positions as the Director-Corporate Strategy at Millennium Pharmaceuticals, Inc. from 2001 to 2007, the Chief Operating Officer at bluebird bio, Inc. from 2016 to 2019, and the SVP-Strategy & Business Integration at Alnylam Pharmaceuticals, Inc. from 2007 to 2016.
Prior to that, she worked as a Management Consultant at Accenture LLC from 1996 to 2001.
Ms. High also served as the Chief Operating Officer at Dyne Therapeutics, Inc. from 2020 to 2024.
She graduated from the University of Bocconi and holds an MBA from MIT Sloan School of Management, which she received in 1996.

Cargos activos de Susanna High

EmpresasCargoInicio
Director Ejecutivo 21/11/2024

Antiguos cargos conocidos de Susanna High.

EmpresasCargoFin
DYNE THERAPEUTICS, INC. Director de Operaciones 01/10/2024
GENETIX BIOTHERAPEUTICS, INC. Director de Operaciones 04/01/2019
ALNYLAM PHARMACEUTICALS, INC. Director/Miembro de la Junta 01/06/2008
Corporate Officer/Principal 01/01/2007
Corporate Officer/Principal 01/01/2001
Ver el detalle de la experiencia de Susanna High.

Formación de Susanna High.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

83

Relaciones de 1er grado

8

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas8

Health Technology

Health Technology

Health Technology

Consumer Services

Commercial Services

Consumer Services

Health Technology

Commercial Services